Company Info
| Phone: | (858)-779-3100 |
| Year Established: | 2015 |
| Ticker: | OTCMKTS |
| Exchange: | RHHBY |
Contacts
| Primary: | Kristin Yarema, Ph.D. President & CEO |
| Other: | Harry J. Leonhardt, Esq General Counsel Johanna Mylet, C.P.A. CFO Loren Wagner COO |
Company Description
Poseida Therapeutics, a Roche company, is a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.
